Quantitative Testing of Patient and Healthcare Provider Knowledge, Attitudes, and Behavior About NATPARA® (Parathyroid Hormone) for Injection, for Subcutaneous Use (NATPARA KAB)

  • STATUS
    Recruiting
  • End date
    Dec 31, 2023
  • participants needed
    200
  • sponsor
    Shire
Updated on 25 October 2022
natpara

Summary

This main aim of this study is to check the level of knowledge and assess attitudes and behaviors of both participants and physicians regarding the risks and safe use of NATPARA. The survey will be done via internet, telephone, or paper and participants will be able to choose the method that is preferred. No study medicines will be provided to patients in this study.

Details
Condition Hypoparathyroidism
Treatment No intervention
Clinical Study IdentifierNCT05556629
SponsorShire
Last Modified on25 October 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

• Participants who are 18 years of age or older and who have been approved for NATPARA and
a part of the SUP Program prior to survey implementation are eligible to participate in the
survey. A caregiver may participate in this survey on behalf of a participant who is a part
of the SUP Program and who is eligible but unable to complete the survey
Prescriber inclusion criteria
• HCPs in the United States (US) who can provide a 10-digit NPI number and who are
certified in the NATPARA REMS by successfully completing the NATPARA REMS Program Training
Module for Prescribers, including the Knowledge Assessment, and submitting a NATPARA REMS
Program Prescriber Enrollment Form are eligible for participation in the survey and a part
of the SUP Program

Exclusion Criteria

Respondents who do not agree to participate in the survey will be excluded
Survey respondents who have been employed or whose immediate family members have been
employed by NPS, Shire, Takeda, UBC, or the Food and Drug Administration (FDA) are not
eligible to participate in the survey and will be excluded
Respondents who reported having a conflict of interest will be excluded
Respondents who are not part of the SUP program will be excluded
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note